Scott Gottlieb
FDA regulatory maze: China has replaced the U.S. as the global hub for biotech drug development
Five years ago, U.S. pharmaceutical companies didn’t license any new drugs from China. By 2024, one-third of their new compounds were coming ...
Viewpoint: Dr. AI? Artificial intelligence on a path to diagnose conditions and prescribe treatments directly to a patient without a physician
The inevitable question isn’t so much if but when these artificial intelligence devices can step into the shoes of doctors ...
After the success of at-home COVID tests, what’s the future for at-home diagnostics?
The response to the COVID-19 pandemic in the US has been transformed through new technologies. The speed of progress in ...
Viewpoint: Success of home COVID tests should encourage FDA to open regulatory door to more at-home diagnostics
The response to the COVID-19 pandemic in the US has been transformed through new technologies. The speed of progress in ...
Viewpoint: What can we learn from the Bush Administration’s effort against AIDS as we battle COVID in developing countries?
In 2004 [AIDS] was burning across Africa. Treatments were available but expensive, and everyone wanted to expand Africa’s access to ...
Viewpoint: ‘It’s not a political statement’ – Former FDA chief Scott Gottlieb calls for nationwide mask mandate
As deaths rise this winter, policy makers will have to take new steps to slow the rate of spread. There ...
Getting past the coronavirus: ‘A road map to reopening’ by the American Enterprise Institute
Executive Summary This report provides a road map for navigating through the current COVID-19 pandemic in the United States. It ...
Viewpoint: Coronavirus testing, treatment key to ending national lockdowns
First, the bad news: America’s coronavirus epidemic is only beginning, and the suffering will become more searing over the next ...
Would price controls hamper research on gene therapy and other innovative treatments?
Over the next decade, it is a near certainty that we will have gene-therapy cures for deadly inherited disorders such ...
FDA announces controversial ‘risk-based’ rules for CRISPR-edited animal technology
Novel biotechnology, like genome editing, holds tremendous potential to improve animal health, enhance farm productivity, improve nutrition, and even reduce ...
US FDA: Gene-edited crops can have many advantages for consumers
Scientific advances in biotechnology, such as genome editing and synthetic biology, hold enormous potential to improve human and animal health, ...
FDA seeks to regulate your cells
A recent decision by a federal trial court gave the Food and Drug Administration the latitude that the agency has ...